Table 2 HIV, hepatitis B and C prevalence by gender and injector status. (n = 353 Couples).
From: Recruitment of heterosexual couples in public health research: a study protocol
| Â | Females | Males |
|---|---|---|
HIV (% positive) | Â | Â |
   Total sample (N = 335 females, 341 males) | 22.1 | 22.0 |
   Ever injectors (N = 218 females, 221 males) | 24.8 | 26.2 |
   Current injectors (N = 128 females, 125 males) | 16.4 | 24.8 |
Hepatitis B (% anti-HBV reactive) | Â | Â |
   Total sample (N = 297 females, 301 males) | 43.1 | 47.8 |
   Ever injectors (N = 185 females, 191 males) | 49.7 | 61.3 |
   Current injectors (N = 108 females, 107 males) | 46.3 | 60.8 |
Hepatitis C (% anti-HCV reactive) | Â | Â |
   Total sample (N = 297 females, 302 males) | 51.5 | 52.7 |
   Ever injectors (N = 185 females, 191 males) | 73.5 | 74.4 |
   Current injectors (N = 108 females, 107 males) | 75.0 | 73.8 |